Bilimoria Karl Y, Bentrem David J, Ko Clifford Y, Stewart Andrew K, Winchester David P, Talamonti Mark S, Sturgeon Cord
Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Ann Surg. 2007 Sep;246(3):375-81; discussion 381-4. doi: 10.1097/SLA.0b013e31814697d9.
The extent of surgery for papillary thyroid cancers (PTC) remains controversial. Consensus guidelines have recommended total thyroidectomy for PTC > or =1 cm; however, no study has supported this recommendation based on a survival advantage. The objective of this study was to examine whether the extent of surgery affects outcomes for PTC and to determine whether a size threshold could be identified above which total thyroidectomy is associated with improved outcomes.
From the National Cancer Data Base (1985-1998), 52,173 patients underwent surgery for PTC. Survival was estimated by the Kaplan-Meier method and compared using log-rank tests. Cox Proportional Hazards modeling stratified by tumor size was used to assess the impact of surgical extent on outcomes and to identify a tumor size threshold above which total thyroidectomy is associated with an improvement in recurrence and long-term survival rates.
Of the 52,173 patients, 43,227 (82.9%) underwent total thyroidectomy, and 8946 (17.1%) underwent lobectomy. For PTC <1 cm extent of surgery did not impact recurrence or survival (P = 0.24, P = 0.83). For tumors > or =1 cm, lobectomy resulted in higher risk of recurrence and death (P = 0.04, P = 0.009). To minimize the influence of larger tumors, 1 to 2 cm lesions were examined separately: lobectomy again resulted in a higher risk of recurrence and death (P = 0.04, P = 0.04).
The results of this study demonstrate that total thyroidectomy results in lower recurrence rates and improved survival for PTC > or =1.0 cm compared with lobectomy. This is the first study to demonstrate that total thyroidectomy for PTC > or =1.0 cm improves outcomes.
甲状腺乳头状癌(PTC)的手术范围仍存在争议。共识指南推荐对直径大于或等于1厘米的PTC行全甲状腺切除术;然而,尚无研究基于生存优势支持这一推荐。本研究的目的是探讨手术范围是否会影响PTC的预后,并确定是否能找出一个大小阈值,超过该阈值后全甲状腺切除术与更好的预后相关。
从国家癌症数据库(1985 - 1998年)中,52173例患者接受了PTC手术。采用Kaplan-Meier法估计生存率,并使用对数秩检验进行比较。采用按肿瘤大小分层的Cox比例风险模型评估手术范围对预后的影响,并确定一个肿瘤大小阈值,超过该阈值后全甲状腺切除术与复发率和长期生存率的改善相关。
在52173例患者中,43227例(82.9%)接受了全甲状腺切除术,8946例(17.1%)接受了甲状腺叶切除术。对于直径小于1厘米的PTC,手术范围不影响复发或生存(P = 0.24,P = 0.83)。对于直径大于或等于1厘米的肿瘤,甲状腺叶切除术导致更高的复发和死亡风险(P = 0.04,P = 0.009)。为尽量减少较大肿瘤的影响,对1至2厘米的病变进行单独分析:甲状腺叶切除术再次导致更高的复发和死亡风险(P = 0.04,P = 0.04)。
本研究结果表明,与甲状腺叶切除术相比,全甲状腺切除术可降低直径大于或等于1.0厘米的PTC的复发率并改善生存。这是第一项证明对直径大于或等于1.0厘米的PTC行全甲状腺切除术可改善预后的研究。